GBT
Global Blood Therapeutics, Inc.
Delisted
GBT was delisted on the 4th of October, 2022.
116 hedge funds and large institutions have $1.16B invested in Global Blood Therapeutics, Inc. in 2017 Q1 according to their latest regulatory filings, with 45 funds opening new positions, 41 increasing their positions, 25 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
42% more call options, than puts
Call options by funds: $19M | Put options by funds: $13.4M
21% more funds holding
Funds holding: 96 → 116 (+20)
Holders
116
Holding in Top 10
6
Calls
$19M
Puts
$13.4M
Top Buyers
| 1 | +$94.5M | |
| 2 | +$53.6M | |
| 3 | +$40M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$29.7M |
| 5 |
PA
Perceptive Advisors
New York
|
+$26.9M |
Top Sellers
| 1 | -$28.8M | |
| 2 | -$25.8M | |
| 3 | -$10.5M | |
| 4 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
-$9.84M |
| 5 |
Prudential Financial
Newark,
New Jersey
|
-$8.22M |